Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[LutherTiggs]

Regardless of FDA issues, neutraceutical path is/was a deadend business model...at least for now without full scientific validation of efficacy and backing of medical/research community. New path might not be a "long time" with future appreciation IF/WHEN RCPI gains a partner, European/US formal trials begin (and results from phase 2 become known either officially or unofficially), etc.